Leelyn Smith
TMO icon

Leelyn Smith’s Thermo Fisher Scientific TMO Stock Holding History

Leelyn Smith’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.61M Buy
9,789
+77
+0.8% +$45.7K 0.73% 30
2026
Q2 		$4.87M Buy
9,712
+361
+4% +$173K 0.59% 48
2026
Q1 		$4.6M Buy
9,351
+475
+5% +$258K 0.64% 42
2025
Q4 		$5.14M Buy
8,876
+169
+2% +$95.6K 0.74% 34
2025
Q3 		$4.22M Buy
8,707
+501
+6% +$233K 0.64% 39
2025
Q2 		$3.33M Buy
8,206
+601
+8% +$251K 0.55% 46
2025
Q1 		$3.78M Buy
7,605
+397
+6% +$215K 0.67% 39
2024
Q4 		$3.75M Buy
7,208
+228
+3% +$125K 0.67% 39
2024
Q3 		$4.32M Buy
6,980
+257
+4% +$152K 0.78% 33
2024
Q2 		$3.72M Buy
6,723
+200
+3% +$115K 0.72% 36
2024
Q1 		$3.79M Buy
6,523
+159
+2% +$89.2K 0.76% 36
2023
Q4 		$3.38M Buy
6,364
+486
+8% +$235K 0.74% 37
2023
Q3 		$2.98M Buy
5,878
+290
+5% +$155K 0.73% 39
2023
Q2 		$2.92M Buy
+5,588
New +$3.02M 0.7% 38
2023
Q1 		– Sell
-150
Closed -$82.6K – 399
2022
Q4 		$82.6K Buy
150
+110
+275% +$58.3K 0.02% 139
2022
Q3 		$20K Sell
40
-550
-93% -$308K 0.01% 231
2022
Q2 		$320K Buy
590
+295
+100% +$162K 0.08% 103
2022
Q1 		$174K Hold
295
– – 0.05% 122
2021
Q4 		$197K Hold
295
– – 0.05% 118
2021
Q3 		$169K Hold
295
– – 0.05% 117
2021
Q2 		$149K Buy
295
+11
+4% +$5.19K 0.04% 133
2021
Q1 		$130K Hold
284
– – 0.04% 149
2020
Q4 		$132K Sell
284
-335
-54% -$157K 0.04% 140
2020
Q3 		$273K Hold
619
– – 0.1% 104
2020
Q2 		$224K Sell
619
-197
-24% -$66K 0.09% 109
2020
Q1 		$231K Sell
816
-65
-7% -$20.5K 0.12% 99
2019
Q4 		$289K Buy
+881
New +$267K 0.14% 94

Other funds holding TMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Leelyn Smith's TMO Position: Q3 2026 in Review

Leelyn Smith increased its Thermo Fisher Scientific (TMO) stake by 0.79% in Q3 2026, buying an estimated $45.7K and bringing the position to 9,789 shares worth $6.61M. The position accounts for 0.73% of the portfolio, ranked #30.

Leelyn Smith first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Leelyn Smith held 9,789 shares of Thermo Fisher Scientific worth $6.61M as of Q3 2026.
  • Leelyn Smith bought 77 Thermo Fisher Scientific shares in Q3 2026, an estimated $45.7K.
  • Thermo Fisher Scientific made up 0.73% of Leelyn Smith's portfolio in Q3 2026, its #30 holding.
  • Leelyn Smith first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • 1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Leelyn Smith's 13F filing for Q3 2026, filed 3 Nov 2026.